Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intra-Cellular Therapies Inc ITCI

Healthcare
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical... see more

Recent & Breaking News (NDAQ:ITCI)

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intra-Cellular Therapies, Inc. (ITCI) and Lead Plaintiff Deadline - July 11, 2017

GlobeNewswire July 11, 2017

DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Reminds Investors with Losses to Contact the Firm

GlobeNewswire July 10, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zoompass Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – ZPAS

Business Wire July 7, 2017

ITCI  NOTICE: Rosen Law Firm Reminds Intra-Cellular Therapies, Inc. Investors of Important July 11 Deadline in First Filed Class Action – ITCI

GlobeNewswire July 7, 2017

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $250,000 in United Technologies Corporation to Contact the Firm

Business Wire July 5, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mattel, Inc. – MAT

Business Wire June 28, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intra-Cellular Therapies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2017 – ITCI

GlobeNewswire June 26, 2017

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Intra-Cellular Therapies, Inc. to Contact the Firm

Business Wire June 19, 2017

The Klein Law Firm Reminds Investors of a Class Action on Behalf of Intra-Cellular Therapies, Inc. Shareholders and a Lead Plaintiff Deadline of July 11, 2017

GlobeNewswire June 19, 2017

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Reminds Investors with Losses to Contact the Firm

GlobeNewswire June 9, 2017

ITCI ALERT: Rosen Law Firm Reminds Intra-Cellular Therapies, Inc. Investors of Important Deadline in First Filed Class Action – ITCI

GlobeNewswire June 9, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intra-Cellular Therapies, Inc. of Class Action Lawsuit and Upcoming Deadline – ITCI

GlobeNewswire June 9, 2017

ITCI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intra-Cellular Therapies, Inc. and a Lead Plaintiff Deadline of July 11, 2017

GlobeNewswire June 9, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intra-Cellular Therapies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2017 – ITCI

GlobeNewswire June 8, 2017

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Roche Holding AG and Encourages Investors with Losses to Contact the Firm

Business Wire June 8, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intra-Cellular Therapies, Inc. (ITCI) and Lead Plaintiff Deadline: July 11, 2017

GlobeNewswire June 8, 2017

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

GlobeNewswire June 7, 2017

The Klein Law Firm Reminds Investors of Commencement of a Class Action on Behalf of Intra-Cellular Therapies, Inc. Shareholders and a Lead Plaintiff Deadline of July 11, 2017

Business Wire June 7, 2017

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Intra-Cellular Therapies, Inc. Investors and Encourages Investors to Contact the Firm

Business Wire June 6, 2017

The Klein Law Firm Announces a Class Action Filed on Behalf of Intra-Cellular Therapies, Inc. Shareholders and a Lead Plaintiff Deadline of July 11, 2017

Business Wire June 6, 2017